The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/II study of niraparib combination therapies for the treatment of metastatic castration-resistant prostate cancer (NCT03431350).
 
Sumit Kumar Subudhi
Honoraria - Apricity Health; Compugen; Dendreon; Janssen
Consulting or Advisory Role - Apricity Health; Dendreon; Janssen; Polaris; Valeant/Dendreon
Travel, Accommodations, Expenses - Compugen; Dendreon; Janssen
 
Ana Aparicio
Honoraria - Biosense Webster (I); Boston Scientific (I); Genzyme
Consulting or Advisory Role - American Cancer Society; American Cancer Society; Biosense Webster (I); Boston Scientific (I); Bristol-Myers Squibb; GlaxoSmithKline; Janssen Research & Development
Speakers' Bureau - Biosense Webster (I); Boston Scientific (I)
Research Funding - BioSense Webster (I); Boston Scientific (I); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Hansen Medical (I); Janssen (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Two (I)
Travel, Accommodations, Expenses - Biosense WEbster (I)
 
Amado J. Zurita
Honoraria - Exelixis; Janssen Oncology
Consulting or Advisory Role - Exelixis
Research Funding - Infinity Pharmaceuticals; Pfizer
 
Bernard Doger
No Relationships to Disclose
 
William Kevin Kelly
Honoraria - Constellation Pharmaceuticals; Janssen Oncology
Consulting or Advisory Role - Foundation Medicine; Sanofi
Research Funding - Bayer (Inst); Endocyte (Inst); Exelixis (Inst); Janssen Oncology (Inst); Novartis (Inst); Sanofi (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Janssen Oncology
 
Avivit Peer
Consulting or Advisory Role - Astellas Oncology; Bristol-Myers Squibb; Eisai; Janssen; MSD; Novartis; Pfizer; Roche
 
Dana E. Rathkopf
Consulting or Advisory Role - Genentech/Roche; Janssen Oncology; TRACON Pharma
Research Funding - AstraZeneca (Inst); Celgene (Inst); Ferring (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Medivation (Inst); Millennium (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TRACON Pharma (Inst)
 
Lawrence Ivan Karsh
Stock and Other Ownership Interests - Swan Valley Medical
Honoraria - Astellas Pharma; Bayer; Dendreon; Janssen; Pfizer
Consulting or Advisory Role - 3D Biopsy; Abbvie; Astellas Pharma; Augmenix; Bayer; Dendreon; Ferring; Janssen; Pfizer; Precision Biopsy; Spectrum Pharmaceuticals
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Dendreon; Janssen; Pfizer
Research Funding - Astellas Pharma (Inst); Augmenix (Inst); Bayer (Inst); CU Optics (Inst); Dendreon (Inst); Exact Sciences (Inst); Ferring (Inst); FKD Therapies (Inst); Genomic Health (Inst); Janssen (Inst); Merck (Inst); Myovant Sciences (Inst); Nucleix (Inst); Nymox (Inst); OPKO Biologics (Inst); Pfizer (Inst); Pharmatech/Veru (Inst); Precision Biopsy (Inst); PrecisionMed (Inst); Roche (Inst); Siemens (Inst); Spectrum Pharmaceuticals (Inst); Urogen pharma (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; dendreon; Janssen; Pfizer; Spectrum Pharmaceuticals
 
Jeffrey J. Tryon
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Nishi Kothari
Employment - Janssen
Stock and Other Ownership Interests - Janssen
Travel, Accommodations, Expenses - Janssen
 
Xin Zhao
Employment - Janssen
Stock and Other Ownership Interests - Janssen
Travel, Accommodations, Expenses - Janssen
 
Eugene Zhu
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Deborah S. Ricci
Employment - Janssen
Stock and Other Ownership Interests - Janssen
Patents, Royalties, Other Intellectual Property - Janssen
 
Namphuong Tran
Employment - Janssen
Stock and Other Ownership Interests - Janssen
Travel, Accommodations, Expenses - Janssen
 
Johann S. De Bono
Honoraria - Astellas Pharma; AstraZeneca; BioExcel; Daiichi Sankyo; Genentech/Roche; Janssen Oncology; Menarini Silicon Biosystems; Pfizer; Sanofi; Sierra Oncology
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BioXCel therapeutics; Boehringer Ingelheim; Celgene; Daiichi Sankyo; Eisai; Genentech/Roche; Genmab; GlaxoSmithKline; Janssen Oncology; Menarini Silicon Biosystems; Merck Serono; Merck Sharp & Dohme; Orion; Pfizer; Sanofi; Sierra Oncology; Taiho Pharmaceutical
Research Funding - Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); CellCentric (Inst); Daiichi Sankyo (Inst); Genentech (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Medivation (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Orion (Inst); Sanofi (Inst); Sierra Oncology (Inst); Taiho Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - Abiraterone Rewards to Inventors (Inst); CHK1 inhibitor (Inst); PARP inhibitors and DNA repair defects (Inst); Targeting of IL23 in prostate cancer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Genmab; GlaxoSmithKline; Orion; Qiagen; Sanofi; Taiho Pharmaceutical; Vertex